Lebanese Ministry of Public Health — Pharmacy Department
MoPH-Pharmacy · Lebanon · middle east
Lebanon's Ministry of Public Health Pharmacy Department — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.
Regulatory Profile
- Agency type
- national regulator
- Region
- middle east
- Country
- Lebanon
- Leech status
- unregulated
- Last ASH review
- 2026-05-26
- Website
- https://www.moph.gov.lb
Relevant Regulation Codes
- Lebanese national pharmaceutical law
- Lebanese national medical device regulatory framework
Prescriber Requirements
- Lebanese Order of Physicians–registered physician — order required for any biomedical device application
- Allied health professional application under physician supervision per institutional protocol
Supply Chain & GMP
Ministry of Public Health registration as applicable; Arabic, French, and English-language labelling depending on category. Standard cold-chain conditions.
Import/Export Rules
Ministry of Public Health import authorisation; Ministry of Agriculture veterinary clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.
Reimbursement Context
Not covered under public insurance schemes for leech therapy specifically.
ASH Editorial Notes
Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Lebanon's pharmaceutical sector includes both Ministry of Public Health authority and the Order of Pharmacists; coordination on live-organism medical devices has not been independently mapped by ASH.
Related Jurisdictions
Israeli MoH — Israel
Israel's Ministry of Health (Misrad HaBri'ut) — leech therapy regulated under the Pharmacists' Ordinance with Medical Devices Division oversight; significant clinical use in reconstructive and microsurgery services.
EDA — Egypt
Egypt's Egyptian Drug Authority (formed 2019, replacing the older CAPA / Central Administration of Pharmaceutical Affairs) — leech therapy regulated as a medical device with parallel traditional-medicine context.
SFDA — Saudi Arabia
Saudi Arabia's SFDA — leech therapy supervised under medical-device pathway, with Saudi Vision 2030 expansion of traditional/complementary medicine via NCCAM-KSA at the Ministry of Health.
MOHAP — United Arab Emirates
UAE Ministry of Health and Prevention — federal authority over health products; leech-specific regulation has not been independently verified by ASH.